{"cdcTestId":"2013-0314","testcaseName":"#4 at 7 years","vaccineGroup":"HIB","evaluationTestType":"Age: Too Old","forecastTestType":"Not recommended: too old","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2016-10-19T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Aged out","administeredDoses":[{"dateAdministered":"2016-12-19T00:00:00","vaccineName":"ACTHIB","cvx":"48","mvx":"PMC","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2017-02-19T00:00:00","vaccineName":"ACTHIB","cvx":"48","mvx":"PMC","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2017-06-19T00:00:00","vaccineName":"ACTHIB","cvx":"48","mvx":"PMC","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"ACTHIB","cvx":"48","mvx":"PMC","evaluationStatus":"Extraneous","evaluationReason":"Age: Too Old"}]},"forecast":{"forecastNum":"-","earliestDate":"0001-01-01T00:00:00","recommendedDate":"0001-01-01T00:00:00","pastDueDate":"0001-01-01T00:00:00"},"doses":[{"dateAdministered":"2016-12-19T00:00:00","vaccineName":"ACTHIB","cvx":"48","mvx":"PMC","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2017-02-19T00:00:00","vaccineName":"ACTHIB","cvx":"48","mvx":"PMC","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2017-06-19T00:00:00","vaccineName":"ACTHIB","cvx":"48","mvx":"PMC","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"ACTHIB","cvx":"48","mvx":"PMC","evaluationStatus":"Extraneous","evaluationReason":"Age: Too Old"}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2020-05-26T11:14:17.228","generalDescription":"This test case describes when a child is administered the fourth dose of the Hib vaccine at 7 years of age that the dose is considered to be Extraneous.  No further doses should be forecast.  Series is complete.","changedInVersion":"3.5","reasonForChange":"V3.5: Lowered age of last vaccination from 7 years to 6 years to better align with new Age Groupings. No impact on test case expectations.\nv1.6: Updated Series Status from \u0022Not Complete\u0022 to \u0022Aged Out\u0022 to align with updated CDSi Logic Specification Series Statuses.\nv1.2: Within the scope of the CDSi effort, Hib on or after 5 years is not recommended.  The last administered dose was changed to Extraneous to reflect this."}